tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LGND Stock Latest News

Ligand Pharma Completes $460M Convertible Notes Offering
Company AnnouncementsLigand Pharma Completes $460M Convertible Notes Offering
9d ago
8K
LGND
Ligand Pharmaceuticals Inc. Reports Strong Q2 Earnings
PremiumCompany Announcements
Ligand Pharmaceuticals Inc. Reports Strong Q2 Earnings
12d ago
LGND
Ligand Pharma Announces $400M Convertible Notes Offering
PremiumCompany Announcements
Ligand Pharma Announces $400M Convertible Notes Offering
12d ago
8K
LGND
Ligand announces proposed offering of $400M of convertible senior notes
PremiumThe Fly
Ligand announces proposed offering of $400M of convertible senior notes
13d ago
LGND
Ligand price target raised to $160 from $135 at Benchmark
PremiumThe Fly
Ligand price target raised to $160 from $135 at Benchmark
15d ago
LGND
Ligand price target raised to $185 from $155 at RBC Capital
PremiumThe FlyLigand price target raised to $185 from $155 at RBC Capital
15d ago
LGND
Ligand Pharmaceuticals Reports Strong Q2 2025 Results
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q2 2025 Results
16d ago
LGND
Positive Outlook on Ligand Pharma: Strong Financial Performance and Strategic Positioning Drive Buy Rating
Premium
Ratings
Positive Outlook on Ligand Pharma: Strong Financial Performance and Strategic Positioning Drive Buy Rating
16d ago
LGND
Ligand raises FY25 adjusted EPS view to $6.70-$7.00 from $6.00-$6.25
PremiumThe Fly
Ligand raises FY25 adjusted EPS view to $6.70-$7.00 from $6.00-$6.25
17d ago
LGND
Ligand reports Q2 adjusted EPS $1.60, consensus $1.42
PremiumThe Fly
Ligand reports Q2 adjusted EPS $1.60, consensus $1.42
17d ago
LGND
Orchestra BioMed secures over $111M in proceeds, committed capital
PremiumThe Fly
Orchestra BioMed secures over $111M in proceeds, committed capital
19d ago
MDT
LGND
LGND Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LGND Earnings this Week: How Will it Perform?
19d ago
LGND
Ligand price target raised to $162 from $145 at Oppenheimer
PremiumThe FlyLigand price target raised to $162 from $145 at Oppenheimer
24d ago
LGND
Ligand management to meet with Oppenheimer
Premium
The Fly
Ligand management to meet with Oppenheimer
1M ago
LGND
Ligand partner Pelthos launches ZELSUVMI topical gel
Premium
The Fly
Ligand partner Pelthos launches ZELSUVMI topical gel
1M ago
LGND
Ligand Pharma Completes Merger Forming Pelthos Therapeutics
PremiumCompany Announcements
Ligand Pharma Completes Merger Forming Pelthos Therapeutics
2M ago
8K
LGND
Ligand announces completion of Pelthos Therapeutics merger with Channel
PremiumThe Fly
Ligand announces completion of Pelthos Therapeutics merger with Channel
2M ago
LGND
Pelthos Therapeutics completes merger with Channel Therapeutics
PremiumThe Fly
Pelthos Therapeutics completes merger with Channel Therapeutics
2M ago
LGND
Ligand Pharma Elects Board Members at Annual Meeting
PremiumCompany Announcements
Ligand Pharma Elects Board Members at Annual Meeting
3M ago
8K
LGND
Ligand price target raised to $145 from $142 at Oppenheimer
PremiumThe FlyLigand price target raised to $145 from $142 at Oppenheimer
4M ago
LGND
Ligand Pharma’s Strong Q1 Performance and Strategic Moves Justify Buy Rating with $135 Price Target
Premium
Ratings
Ligand Pharma’s Strong Q1 Performance and Strategic Moves Justify Buy Rating with $135 Price Target
4M ago
LGND
Ligand Pharmaceuticals Reports Strong Q1 2025 Revenue Growth
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q1 2025 Revenue Growth
4M ago
LGND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >